Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen E Braun

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
AIDS Research and Therapy|October 19, 2007
Instability of retroviral vectors with HIV-1-specific RT aptamers due to cryptic splice sites in the U6 promoterStephen E Braun, Xuanling Shi, Gang Qiu, et al.
Medicines (Basel, Switzerland)|March 3, 2019
The Membrane-Active Phytopeptide Cycloviolacin O2 Simultaneously Targets HIV-1-infected Cells and Infectious Viral Particles to Potentiate the Efficacy of Antiretroviral DrugsSamantha L Gerlach, Partha K Chandra, Upal Roy, et al.
Gastroenterology|February 28, 2007
Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestineSeung G Kang, Ronald J Piniecki, Harm Hogenesch, et al.
Plos One|August 12, 2024
Extracellular domain, hinge, and transmembrane determinants affecting surface CD4 expression of a novel anti-HIV chimeric antigen receptor (CAR) constructGiorgio Zenere, Chengxiang Wu, Cecily C Midkiff, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Extracellular domain, hinge, and transmembrane determinants affecting surface CD4 expression of a novel anti-HIV chimeric antigen receptor (CAR) constructGiorgio Zenere, Chengxiang Wu, Cecily C Midkiff, et al.
Journal of Medical Primatology|August 21, 2014
A novel real-time CTL assay to measure designer T-cell function against HIV Env(+) cellsAndrew G MacLean, Edith Walker, Gautam K Sahu, et al.
Frontiers in Oncology|September 1, 2022
Targeting TRAF3IP2 inhibits angiogenesis in glioblastomaAmin Izadpanah, Fatemeh Daneshimehr, Kurtis Willingham, et al.
Shock (Augusta, Ga.)|April 22, 2023
EXOSOMES AND MICROVESICLES FROM ADIPOSE-DERIVED MESENCHYMAL STEM CELLS PROTECTS THE ENDOTHELIAL GLYCOCALYX FROM LPS INJURYSharven Taghavi, Sarah Abdullah, Farhana Shaheen, et al.
Frontiers in Immunology|April 7, 2022
Biallelic, Selectable, Knock-in Targeting of CCR5 <i>via</i> CRISPR-Cas9 Mediated Homology Directed Repair Inhibits HIV-1 ReplicationStefan H Scheller, Yasmine Rashad, Fayez M Saleh, et al.
Oncotarget|July 25, 2018
TRAF3IP2, a novel therapeutic target in glioblastoma multiformeEckhard U Alt, Zahra Barabadi, Andreas Pfnür, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
AIDS Research and Therapy|October 19, 2007
Instability of retroviral vectors with HIV-1-specific RT aptamers due to cryptic splice sites in the U6 promoterStephen E Braun, Xuanling Shi, Gang Qiu, et al.
Medicines (Basel, Switzerland)|March 3, 2019
The Membrane-Active Phytopeptide Cycloviolacin O2 Simultaneously Targets HIV-1-infected Cells and Infectious Viral Particles to Potentiate the Efficacy of Antiretroviral DrugsSamantha L Gerlach, Partha K Chandra, Upal Roy, et al.
Gastroenterology|February 28, 2007
Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestineSeung G Kang, Ronald J Piniecki, Harm Hogenesch, et al.
Plos One|August 12, 2024
Extracellular domain, hinge, and transmembrane determinants affecting surface CD4 expression of a novel anti-HIV chimeric antigen receptor (CAR) constructGiorgio Zenere, Chengxiang Wu, Cecily C Midkiff, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Extracellular domain, hinge, and transmembrane determinants affecting surface CD4 expression of a novel anti-HIV chimeric antigen receptor (CAR) constructGiorgio Zenere, Chengxiang Wu, Cecily C Midkiff, et al.
Journal of Medical Primatology|August 21, 2014
A novel real-time CTL assay to measure designer T-cell function against HIV Env(+) cellsAndrew G MacLean, Edith Walker, Gautam K Sahu, et al.
Frontiers in Oncology|September 1, 2022
Targeting TRAF3IP2 inhibits angiogenesis in glioblastomaAmin Izadpanah, Fatemeh Daneshimehr, Kurtis Willingham, et al.
Shock (Augusta, Ga.)|April 22, 2023
EXOSOMES AND MICROVESICLES FROM ADIPOSE-DERIVED MESENCHYMAL STEM CELLS PROTECTS THE ENDOTHELIAL GLYCOCALYX FROM LPS INJURYSharven Taghavi, Sarah Abdullah, Farhana Shaheen, et al.
Frontiers in Immunology|April 7, 2022
Biallelic, Selectable, Knock-in Targeting of CCR5 <i>via</i> CRISPR-Cas9 Mediated Homology Directed Repair Inhibits HIV-1 ReplicationStefan H Scheller, Yasmine Rashad, Fayez M Saleh, et al.
Oncotarget|July 25, 2018
TRAF3IP2, a novel therapeutic target in glioblastoma multiformeEckhard U Alt, Zahra Barabadi, Andreas Pfnür, et al.
Pageof 4